• Home>
  • Stocks>
  • Syncom Formulations (India) Ltd Share Price
Syncom Formulations (India) Ltd share price logo

Syncom Formulations (India) Ltd Share Price (SYNCOMF)

₹17.390.06%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Syncom Formulations (India) Ltd Stock Performance

as on August 22, 2025 at 2:54 PM IST

  • Day's Low

    Day's High

    ₹17.18
    ₹17.78
    downward going graph

    1.21%

    Downside

    2.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹14.1
    ₹27.9
    downward going graph

    18.92%

    Downside

    60.44%

    Upside

    downward going graph
Previous Close₹17.40
Open₹17.39
Volume2.37L
Upper Circuit₹18.27
Lower Circuit₹16.53
Day's Low17.18
Day's High17.78
52 Week Low14.1
52 Week High27.9
1 Month Return-4.19 %
3 Month Return-11.72 %
1 Year Return-5.95 %
3 Year Return+ 106.41 %
5 Year Return+ 850.82 %

Syncom Formulations (India) Ltd Stock Fundamentals & Key Indicators

Check Syncom Formulations (India) Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹1,635.60 Cr

Return on Equity (ROE)

8.71

PE Ratio (TTM)

25.97

Return on capital employed (ROCE)

10.32

Industry PE ratio

43.37

Beta (LTM)

1.41

P/B Ratio

3.67

Dividend Yield

0

PEG Ratio

89.55

Quarterly Earnings Growth YOY

106.42

EPS (TTM)

0.27

Sector

Pharmaceuticals

Book Value

3.07

Technical Analysis

Syncom Formulations (India) Ltd Stock's Interest Amongst Investors

0.13%

Period Aug 22, 2025 to Jul 23, 2025. Change in 30 Days vs previous period

Investment in Syncom Formulations (India) Ltd Shares on INDmoney has grown by 0.13% over the past 30 days, indicating increased transactional activity.

-28%

Period Aug 22, 2025 to Jul 23, 2025. Change in 30 Days vs previous period

Search interest for Syncom Formulations (India) Ltd Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Syncom Formulations (India) Ltd Stock Valuation

Track how Syncom Formulations (India) Ltd P/E has moved over time to understand its valuation trends.

Syncom Formulations (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.98x)

March 12, 2020

Today (25.97x)

August 21, 2025

Industry (43.37x)

August 21, 2025

Highest (81.74x)

January 18, 2022

LowHigh

Today’s Price to Earnings Ratio: 25.97x

Syncom Formulations (India) Ltd Financial Results

Get the annual and quarterly financial summary of Syncom Formulations (India) Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

87 (0%)102 (17%)128 (25%)149 (17%)117 (21%)
Net Income

(in ₹ Cr)

8 (0%)11 (46%)13 (17%)18 (36%)16 (11%)
Net Profit Margin8.74% (0%)10.86% (24%)10.19% (6%)11.88% (17%)13.47% (13%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

292 (0%)309 (6%)379 (23%)406 (7%)
Total Liabilities

(in ₹ Cr)

104 (0%)87 (17%)122 (41%)117 (4%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

6 (0%)-2 (135%)16 (893%)10 (36%)-6 (157%)

Syncom Formulations (India) Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Syncom Formulations (India) Ltd.

  • Syncom Formulations (India) Ltd Earnings Results

    Syncom Formulations (India) Ltd’s net profit jumped 106.42% since last year same period to ₹15.75Cr in the Q1 2025-2026. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated -10.97% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Syncom Formulations (India) Ltd Dividends August,2022

    In the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 per share on 13 Aug 2022 - translating a dividend yield of 0.17%.

    Read More about Dividends

Indices Featuring Syncom Formulations (India) Ltd Stock

Check stock indices that include Syncom Formulations (India) Ltd.

BSE Healthcare

₹44,874.87

0.24 (107.67%)

BSE Small-Cap

₹53,104.75

-0.15 (-81.28%)

Syncom Formulations (India) Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Syncom Formulations (India) Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
50.57%
0.00
Foreign Institutions
0.41%
278.00
Mutual Funds
0%
0.00
Retail Investors
49.02%
-0.61
Others
0%
0.00

Syncom Formulations (India) Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Syncom Formulations (India) Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA1,635.60170.16%0.6125263
NA219.61409.45%0.56-1215
NA137.71-11.79%0.001269
NA8.288.75%0.76NA27
NA264.040.76%0.009162

Syncom Formulations (India) Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Syncom Formulations (India) Ltd.

  • Syncom Formulations Reports Exceptional Q4 and FY 2025 Growth - 06 Jun, 2025

    Syncom Formulations (India) Ltd reported remarkable financial results for Q4 and FY 2025, with PAT surging 139% to ₹1,769 lakhs and revenue increasing 76% to ₹46,501 lakhs. Strong growth in both export and domestic markets contributed to this performance.

Insights on Syncom Formulations (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.11% to 0.41% in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 28.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 32.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.57% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 155.83 Cr → 122.98 Cr (in ₹), with an average decrease of 21.1% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 49.32% to 49.02% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 17.69 Cr → 15.75 Cr (in ₹), with an average decrease of 11.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, SYNCOMF stock has moved down by -11.7%

About Syncom Formulations (India) Ltd

Syncom Formulations India is a public limited company that was established in 1988 and converted to public limited in 1992. It manufactures pharmaceutical formulations, injectibles, ear/eye drops, and herbal products such as Edicare Attom Megacaps Ecziguard and Yas antacid salt. The company started its expansion project in 1994 of setting up a new manufacturing plant in Pithampur Madhya Pradesh which was completed in 1995. During the financial year 1998-99, big expansions in the installed capacity and production base, and the introduction of products in the generic OTC and Ethical divisions were made. The exports boasted an increase of more than 100% and received orders worth Rs.700 lacs. It has been approved as a supplier to Central ESI Hospitals and registered for defence services that will augment the sales volume. Syncom Formulations India is continuously working towards growth and aims to significantly increase its product portfolio and customer base.

Revenue: ₹116.90Cr as on June 2025 (Q1 FY26)
Net Profit: ₹15.75Cr as on June 2025 (Q1 FY26)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
OrganisationSyncom Formulations (India) Ltd
HeadquartersIndore
IndustryPharmaceuticals
CEOKedarmal Bankda
E-voting on sharesClick here to vote

Mutual Funds that own Syncom Formulations (India) Ltd Stock

Check out the Mutual Funds with significant holdings in Syncom Formulations (India) Ltd.

FAQs

What is Syncom Formulations (India) Ltd share price today?

Syncom Formulations (India) Ltd share price today stands at ₹17.39, Open: ₹17.39, Previous Close: ₹17.4, High: ₹17.78, Low: ₹17.18, 52 Week High: ₹27.9, 52 Week Low: ₹14.1 as on .

How to buy Syncom Formulations (India) Ltd shares ?

To buy Syncom Formulations (India) Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SYNCOMF or Syncom Formulations (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Syncom Formulations (India) Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Syncom Formulations (India) Ltd?

Today's traded volume of Syncom Formulations (India) Ltd is 2.37L. Which means that 2.37L shares of Syncom Formulations (India) Ltd were bought and sold on the stock market during today's trading session.

What is Syncom Formulations (India) Ltd's market cap today?

Today's market capitalisation of Syncom Formulations (India) Ltd is ₹1,635.60 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Syncom Formulations (India) Ltd?

Syncom Formulations (India) Ltd’s 52 week high is ₹27.9 and 52 week low is ₹14.1. The current share price of Syncom Formulations (India) Ltd is ₹17.39, which is -37.67% down from its 52 week high and 23.33% up from its 52 week low.